Epic endows three faculty positions at UW-Madison

Epic is giving generously to the University of Wisconsin-Madison this holiday season, endowing three faculty associate positions in the computer sciences department.

Epic's founder and CEO Judy Faulkner earned her master's degree in computer sciences from UW-Madison, and she was awarded an honorary doctorate from the university in 2010. In an article postedo on the department's website, she said the gift will help create a talent pool to fill technology jobs. The newly endowed positions will focus on teaching software development, application design and user interfaces.

"Computer scientists will be needed in almost every industry, and there is a significant shortage," Faulkner said. "Through this gift, the UW-Madison computer science faculty will educate more computer scientists to help fill current and future needs."

Already, many UW-Madison graduates work for Epic, with the vendor's campus located in a suburb of Madison.

"Here in the Madison area, Epic is our Microsoft," said Mark Hill, the chair of the computer sciences department at UW-Madison. "It's a huge tech giant right here in our backyard. We're grateful to Judy Faulkner for her longstanding support of our department."

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.